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Background: Preeclampsia was a syndrome of hypertension proteinuria in pregnant women. In failure of pseudo vasculogenesis, there is persistency 
of endothelial and smooth muscle cell of vessel wall in spiral artery. Spiral artery could not be emphasis and lead to relative hypoxia, and oxidative 
stress in placental tissues. Endothelial cell has property to produce nitric oxide (NO) that can dilated vessel. Placenta also produces prorenin, to 
maintain vascular wall tonicity. Therefore, we want to uncover the property of placenta is there any capacity of prorenin, is that prorenin could 
overcome the NO level, or is there any depression of NO production, and any oxidative stress.
Methods: This observational study was used case–control design. We search preeclampsia cases during September-December 2015. We used 
preeclampsia placentas from early and late onset. We collect preeclampsia placentas from Cipto Mangunkusumo and normal placentas from Budi 
Kemuliaan Hospital. We used 30 preeclampsia placentas and 30 normal placentas. Markers measured were NO and prorenin. NO was measured 
using colorimetric assay kit (K262-200/ BioVision), and prorenin was measured using human prorenin enzyme-linked immunosorbent assay kit 
(ab157525/ Abcam). Glutathione (GSH) was measured using Ellman method and malondialdehyde (MDA) using Wills method.
Results: Prorenin concentration between normal and preeclampsia placenta was analyzed using Mann–Whitney and show that there had no 
significant difference between preeclampsia and normal placentas (p=0.23). Besides, NO data analyzed using independent t-test show significant 
differences between preeclampsia and normal placentas (p=0.001). The difference between normal and preeclampsia GSH concentration was not 
significant (p=0.757), besides the difference between normal and preeclampsia MDA concentration was significant (p=0.000).
Conclusion: NO concentration in preeclampsia placenta was increase, higher than normal placenta. There was no effect of preeclampsia on prorenin 
concentration and GSH. There was marked decrease of MDA in preeclampsia placentas.
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INTRODUCTION
Maternal mortality rate is still considered to a health problem. In year 
of 2012, maternal mortality rate was increased to become 359/100,000 
alive birth. Previously, in 2007 it was 228/100,000 alive birth [1]. One 
of the main causes of maternal mortality was hypertension. Besides, 
one of the diseases during gestation that suffers hypertension is 
preeclampsia syndrome.
Preeclampsia syndrome is a symptoms that consists of hypertension 
and proteinuria during gestation [2]. Incidency of preeclampsia in the 
world was about 3% [2]. Otherwise, the ultimate cause of preeclampsia 
syndrome was still in debatable, but some risk factors were considered to 
become the background of this syndrome: Antiphospholipid syndrome, 
gestation history of preeclampsia syndrome in family, diabetes mellitus, 
nullipara, obesity, over 40 years old, and hypertension [3].
Placenta is important organ to support normal pregnancy, because 
it becomes a connection between mother and fetus. Placenta was 
developed since 8-18 weeks of gestation act as modified connecting 
channel and dilated also unresponsive to vasoconstrictors [4]. In 
preeclampsia, placentation was proceed uncompletely caused blood 
pressure increased and had low perfusion. Imbalance between circulate 
angiogenesis factors and maternal response will determine the clinical 
symptomes [5].
Nitric oxide (NO) acts as a strong vasodilator in pregnancies. Increase of 
intravascular lead vascular dilatation and increase of intravascular NO 
allow placental vessel dilated. Many researchers conducted to measure 
NO concentration in pregnancies, but the results were still in doubt.
Bonsaffoh in 2015 conducted study to compare serum NO concentration 
in non-preeclampsia and preeclampsia, showed result increase of 
serum NO in women with preeclampsia than non-preeclampsia. The 
elevation especially NO was increased in early onset than late onset [6]. 
Conversely, Saha in 2013 report that serum NO concentration was 
decreased in preeclampsia syndrome, this finding was parallel to 
Rodriguez finding that the decrease of inducible nitric oxide synthase 
activity (iNOS) in preeclampsia [6-8].
Another vascular marker that could be investigated in preeclampsia was 
prorenin. Prorenin is part of Renin-Angiotensin-Aldosterone system that 
mediates hypertension. Some researchers found prorenin in various 
concentrations in placental tissues of preeclampsia. Therefore, we 
conduct observation research to reveal the concentration of prorenin 
compared to some stress oxidative markers in preeclampsia placentas.
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METHODS
This research was an observational study with cross-sectional design: 
Case–control. The population was preeclampsia syndrome patient. 
Samples were placentas of pregnant women indicated preeclampsia 
that hospitalized at Cipto Mangunkusumo Central Hospital.
Samples collection was according to convenience sampling, 21 
preeclampsia cases, and 24 cases without preeclampsia. Placentas 
that firm to criteria, accepted to this study. Inclusion criteria were 
preeclampsia placenta. Exclusion criteria were preeclampsia with 
infection and gestational hypertension.
Placentas samples were collected from delivery room of Cipto 
Mangunkusumo central Hospital (preeclampsia) and Budi Kemuliaan 
Hospital Jakarta Indonesia, with inform consent. Samples were kept in 
deep freezer −80°C at Biochemistry & Molecular Biology Laboratory, 
Faculty of Medicine, Universitas Indonesia.
NO measurement
Sample homogenate was made from 100 mg placental tissue 
homogenized to be 1 ml in phosphate buffered saline pH 7.4. NO was 
measured using Griess colorimetric assay kit. Every 85 μl sample 
homogenate was mixed with 115 μl PBS pH 7,4 and put into microplate 
well. Furthermore, add into wells each of 5 µl nitrate reductase and then 
5 µl enzyme cofactor followed by incubation for 1 h. After incubation, 
5 µl enhancer was added to each of wells followed by addition of 50 μl 
Griess R1 dan Griess R2 reagent into each of wells. Change of color will 
appeared in 10 min. Absorbances were measured at 540 nm wavelength. 
The result compared with the NO derivatives standard curve.
Glutathione (GSH) measurement
Reduced GSH was measured using Ellman method as same as Latha-
Latha research that used this method to determine GSH in carbon 
tetrachloride liver tissue acute toxicity/injury [9,10]. The principle of 
Ellman reaction: Reduction of Ellman reagent by –SH group to produce 
the yellow color of 5,5’ dithiobis(2-nitrobenzoicacid) [9]. The absorbance 
was measured at 412 nm using Varioskan spectrofluorometer. The 
result was expressed as mg/mg protein.
Malondialdehyde (MDA) measurement
MDA measurement was done using Wills method. 2 ml of placental 
homogenate was added with 1 ml 20% cold tricarboxylic acid and mixed 
using vortex for 1 min followed by centrifugation at 1500 g for 10 min. 
Supernatant liquid was taken and stored at −85°C (deep freezer) before 
used. 200 mL supernatant liquid was added into 2 ml of thiobarbituric 
acid and boiled for 10 min in boiling water. After boiled the mixture let 
stay to be cold at room temperature. The absorbance was measured at 
530 nm using an optical spectrophotometer. The result was expressed 
as nmol/mg protein [9,11].
Measurement of prorenin protein
Prorenin protein was measured using enzyme-linked immunosorbent 
assay kit. Each of 100 μl sample homogenate was added into wells, and 
shaked, followed centrifugation for 30 min. Furthermore, wells washed 
with buffer. After washing, 100 µl prorenin antibody was added into 
each well, and incubated for 30 min. After washing 90 µl substrate was 
added. After 30 min incubation stop solution was added to stop the 
reaction. Absorbances of NO derivatives were measured at 450 nm of 
wavelength.
Statistical analysis
Normality and homogeneity of data show that our data were not 




NO derivatives were measured using colorimetric method. Average 
concentration of NO-derivatives in preeclampsia was 12.532 µM, besides 
normal was 12.083 µM. Statistical analysis using Mann–Whitney show 
significant differences between preeclampsia and normal placentas, 
p=0.002. Although in preeclampsia placentas NO concentrations were 
higher than a normal pregnancy.
Placental prorenin
Placental prorenin average concentration of preeclampsia was 
5.7×10−5 ng/ml. On the other, prorenin average concentration of normal 
placenta was 5.3×10−5 ng/ml. Mann–Whitney statistical analysis 
shows that there was no significant difference of prorenin between 
preeclampsia and normal placentas (p=0.884).
Preeclampsia is a syndrome signed by hypertension and proteinuria, 
divided into two steps. First step appear before 20 weeks of gestation, 
there is an uncompleted changing in spiral is arteries that caused 
failure of placentation. Failure of placentation caused chronic 
uteroplacental ischemia. Second step, the systemic signs expressed 
according to maternal inflammation, imbalance of angiogenesis anti-
angiogenesis [4,9]. Some of angiogenesis markers could be detected 
were vascular endothelial growth factor, but we focus on prorenin and 
NO. Marker for hypoxia and oxidative stress caused by hypoxia were 
MDA, GSH, and enzymes such as superoxide dismutase, peroxidase, 
thioredoxin system, and catalase; we focus on MDA and GSH.
In this study, we found that preeclampsia placentas NO concentration 
significantly higher than non-preeclampsia (normal) placentas (Fig. 1). 
Shaamash et al. report showed that there was higher NOS activity and 
NO production in preeclampsia and preeclampsia [13]. Besides, 
Adu-bonsaffoh et al. also report that there was an increase of NO in 
preeclampsia higher than non-preeclampsia [6]. Otherwise, Ehsanipoor 
found that there was a decreased of placental NO and heme oxygenase-I. 
Furthermore, Ehsanipoor also found that the decrease of NO was 
influenced by placental dimethylarginine dimethylaminotransferase 
(DDAH-H and DDAH-II) [14]. Another study, No et al. report that 
preeclampsia e-NOS expression was lower compared to normal 
placenta [15].
Nitric oxide is a strong vasodilator act on placental vessel relaxation lead 
to adequate placental blood flow. This was proofed by inhibition of NO 
will increased blood pressure of uterine arteries [16]. NO was produced 
by eNOS and iNOS. In gestation, eNOS expression was increased, serum 
NO concentration was increased according to gestational age, and will 
be decreased into concentration before gestation after 12 weeks after 
birth [17]. Decreased NO concentration in circulation and placental was 
conversely to the increased concentration of H2O2 marker of oxidative 
stressed in placentas [18].
Fig. 1: Nitric oxide expression in placentas (µM). There was a 
significant difference of NO between normal and preeclampsia 
placentas (p=0.001)
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In a normal pregnancy, prorenin mRNA relative expression was found 
in chorion, decidua, and placenta [19]. Gestation without complication 
of hypertension, serum prorenin concentration was increase 
following the gestational age. In the third trimester, the decrease of 
prorenin concentration was correlated to complication of gestational 
hypertension [20]. In this study, preeclampsia placental prorenin 
concentration had no significant difference than normal, but tends to 
decreased.
Renin-angiotensin system play role in blood pressure control 
mechanism and electrolyte balance. Prorenin is an inactive precursor 
of renin and has concentration 10 times higher than renin. Prorenin 
activation mechanism to be renin needs proteolytic cleavage by 
protease, and also by a non-proteolytic mechanism through regulation 
of pH and temperature [21].
We found that MDA concentration in early and late preeclampsia 
tissues was very low. We suggest that in preeclampsia placenta the 
amount of reactive oxygen species was very low (Fig. 4) and not enough 
to stimulate signal transduction for placental growth and development. 
However, GSH level in placentas shows no difference between normal 
and preeclampsia. We assumed that GSH level was not change because 
there was no GSH usage by ROS.
CONCLUSION
Concentration of nitric oxide of preeclampsia was higher significantly 
than normal placenta. There was no significant difference of prorenin 
between preeclampsia and normal placenta, and decrease of GSH usage 
that may cause by decrease markedly of ROS production.
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